Popular heartburn drugs linked to serious disease and cancer risks

Popular heartburn drugs have been linked to serious health risks, including increased odds of developing stomach cancer, fatal cardiovascular disease, and chronic kidney disease. The concerns involve long-term use of medications known as proton pump inhibitors (PPIs), which have been previously associated with higher odds of dying prematurely. The findings are detailed in a study out of the Washington University … Continue reading

Mark Zuckerberg Declines to Make Mark Zuckerberg Less Powerful

Mark Zuckerberg is still in power at Facebook.

Read more…

Is Secondhand Vape Bad for You?

You don’t have to look far to find a fresh study suggesting that e-cigarette use isn’t harmless, even if the products are likely less toxic than traditional tobacco cigarettes. But what about people sitting in the same room or living in the same home as someone who vapes? Is there such a thing as secondhand vape? And…

Read more…

This Is By Far The Worst App To Use Post-Breakup

Delete your exes on social media all you want, but your digital detox isn’t complete until you take them off this app.

Planned Parenthood Declares A State Of Emergency Amid Abortion Bans

“This is a man-made disaster that’s years in the making and it’s endangering women’s lives.”

Hoda Kotb Gets Real About Adjusting From 1 Kid To 2

The “Today” host has two daughters, Haley Joy and Hope Catherine.

Cardi B Has An Epic Defense For Getting Plastic Surgery

“I do whatever the f**k I want to do with my body,” the “Bodak Yellow” rapper said.

Chicago Police Release Jussie Smollett Case Documents

The “Empire” actor claims he didn’t stage a racist, homophobic attack against himself. Chicago officials say otherwise.

Wirecutter's best deals: Apple's Smart Keyboard for iPad Pro drops to $80

This post was done in partnership with Wirecutter. When readers choose to buy Wirecutter’s independently chosen editorial picks, it may earn affiliate commissions that support its work. Read Wirecutter’s continuously updated list of deals here.

VR pioneer Leap Motion reportedly sells to UltraHaptics for $30 million

VR/AR startup Leap Motion has been sold to a rival business named UltraHaptics, according to the Wall Street Journal. The price for the company was reportedly around $30 million — it was said to be valued at ten times as much in 2013.